Skip to main content

Cantaloupe, Inc. (CTLP) Stock Forecast

Data as of May 3, 2026

Technology · Current price $10.89 (-0.23%)

Consensus Target
$11.00
Upside
+1.0%
Analysts
Rating

Price Target Range

Low $11.00High $11.00

Consensus Price Target Over Time

Analyst Rating Distribution

Last 3 Months

No ratings in the last 3 months.
Strong Buy0
Buy0
Hold0
Sell0
Strong Sell0

6-Month Trend

No rating trend data.

Latest Analyst Forecasts

Price targets issued by Wall Street analysts. Upside calculated against today's price.

DateAnalystFirmPrice TargetUpside
Sep 11, 2024George SuttonCraig-Hallum$11.00+1.0%

CTLP vs Sector & Market

MetricCTLPTechnology AvgLarge Cap Avg
Analyst Rating2.342.41
Analyst Count1318
Target Upside+1.0%+4072.7%+14.9%
P/E Ratio15.0127.9231.19

Revenue Estimates

PeriodLowAvgHigh#
2026-06-30$93M$93M$93M1
2026-09-30$94M$94M$94M1
2026-12-31$97M$97M$97M1
2027-03-31$98M$98M$98M1
2027-06-30$106M$106M$106M1

EPS Estimates

PeriodLowAvgHigh#
2026-06-30$0.12$0.12$0.121
2026-09-30$0.07$0.07$0.071
2026-12-31$0.08$0.08$0.081
2027-03-31$0.12$0.12$0.121
2027-06-30$0.13$0.13$0.131

Frequently Asked Questions

What is the analyst consensus for CTLP?

The consensus among 0 analysts covering Cantaloupe, Inc. (CTLP) is — with an average price target of $11.00.

What is the highest price target for CTLP?

The highest price target for CTLP is $11.00, set by George Sutton at Craig-Hallum on 2024-09-11.

What is the lowest price target for CTLP?

The lowest price target for CTLP is $11.00, set by George Sutton at Craig-Hallum on 2024-09-11.

How many analysts cover CTLP?

0 analysts have issued ratings for Cantaloupe, Inc. in the past 12 months.

Is CTLP a buy or sell right now?

Based on 0 analyst ratings, CTLP has a consensus rating of — with a +1.0% upside to the consensus target of $11.00.

What are the earnings estimates for CTLP?

Analysts estimate CTLP will report EPS of $0.12 for the period ending 2026-06-30, with revenue estimated at $93M.

Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.